Claim being checked · Version 1 · Reviewed
“Semaglutide is FDA-approved.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Supported with scope. The reviewed evidence supports this exact statement only in the situation described below.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for Semaglutide.
01 · Answer
Supported with scope
FDA approves a specific product for specific uses. The current Wegovy label lists different forms, groups of people, uses, and limits.
- What kind of evidence this is
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- What this answer covers
- The exact semaglutide products, forms, people, and uses named in current FDA labels. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Approval and status. Whether a specific product has an approval or another official status.
02 · Sources
Read the sources behind this answer
01OZEMPIC (semaglutide) prescribing information, revised 05/2026U.S. Food and Drug Administration · Drug label · 2026
Supports the scoped claim02RYBELSUS (semaglutide) prescribing information, revised 10/2025U.S. Food and Drug Administration · Drug label · 2025
Supports the scoped claim03WEGOVY (semaglutide) prescribing information, revised 06/2026U.S. Food and Drug Administration · Drug label · 2026
Supports the scoped claim
Supports the scoped claim02RYBELSUS (semaglutide) prescribing information, revised 10/2025U.S. Food and Drug Administration · Drug label · 2025
Supports the scoped claim03WEGOVY (semaglutide) prescribing information, revised 06/2026U.S. Food and Drug Administration · Drug label · 2026
Supports the scoped claim
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.